1,871 results on '"Ruet A"'
Search Results
102. Abstract 2946: Depleting hCCR8 mAb Therapy #1: Characterization of a broad collection of anti-hCCR8 mAbs
103. Abstract 4961: Novel biased PAR2 inhibitors with best-in-class properties reduce resistance to both chemotherapy and immunotherapy in oncology models
104. The radiologically isolated syndrome: revised diagnostic criteria
105. Influence of the geometry of the feature space on curiosity based exploration
106. Lawsuit and Traumatic Brain Injury: The Relationship Between Long-Lasting Sequelae and Financial Compensation in Litigants. Results From the PariS-TBI Study
107. Cognitive Impairment in Multiple Sclerosis With Regards to Disease Duration and Clinical Phenotypes
108. A Detailed Overview of Long-Term Outcomes in Severe Traumatic Brain Injury Eight Years Post-injury
109. Inclusión de nuevas tecnologías en los sistemas de salud públicos en México: situación regulatoria
110. A comprehensive picture of 4-year outcome of severe brain injuries. Results from the PariS-TBI study
111. Differences in behavior, facial expressions and locomotion between positive anticipation and frustration in horses
112. Geometric Characterization of Hereditarily Bijective Boolean Networks.
113. Geometric Characterization of Hereditarily Bijective Boolean Networks
114. Indian Firms in World Production: The State, Markets, and Innovation
115. The Chinese and Indian Automobile Industry in Perspective: Technology Appropriation, Catching-up and Development
116. Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
117. Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis
118. LC-MS/MS quantification of three C16 sulfatide species in dried blood spots for the diagnosis and treatment monitoring of metachromatic leukodystrophy
119. Behaviours Exhibited During Training Predict Physical Tiredness in Harness Racing Horses
120. Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: a retrospective observational cohort study
121. Botulinum toxin A for treating spasticity in adults: Costly for French hospitals?
122. Assessment of long time approximation equation to determine thermal conductivity of high porous materials with NSS probe
123. Single-Fiber Electromyography Analysis of Botulinum Toxin Diffusion in Patients With Fatigue and Pseudobotulism
124. Advanced LIGO two-stage twelve-axis vibration isolation and positioning platform. Part 2: Experimental investigation and tests results
125. Advanced LIGO two-stage twelve-axis vibration isolation and positioning platform. Part 1: Design and production overview
126. Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system
127. Time to steroids impacts visual outcome of optic neuritis in MOGAD
128. Pregnancy and post-partum in patients with myelin-oligodendrocyte glycoprotein antibody-associated disease
129. Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system
130. Cerebellar Assessment in Early Multiple Sclerosis
131. Differential Gray Matter Vulnerability in the 1 Year Following a Clinically Isolated Syndrome
132. Innovative green-technology SMEs as an opportunity to promote financial de-risking
133. Does galvanic vestibular stimulation reduce spatial neglect? A negative study
134. Validation of a Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) and comparison with reference batteries
135. 1393 Beyond CCR8 key epitopes targeting dynamic CCR8 conformational states and a diversity of monoclonal antibodies to modulate the tumor microenvironment for the treatment of cancers
136. Mass cytometry blood immunophenotyping of RRMS patients at diagnosis helps in deciphering subtle changes in myeloid compartment associated to disease evolution
137. Altered functional brain states predict cognitive decline 5 years after a clinically isolated syndrome
138. Time to steroids impacts visual outcome of optic neuritis in MOGAD
139. Lanthanide complexes (Gd$^{III}$ and Eu$^{III}$) based on a DOTA-TEMPO platform for redox monitoring via relaxivity
140. Horse welfare: A joint assessment of four categories of behavioural indicators using the AWIN protocol, scan sampling and surveys
141. 1393 Beyond CCR8 key epitopes targeting dynamic CCR8 conformational states and a diversity of monoclonal antibodies to modulate the tumor microenvironment for the treatment of cancers
142. When a Great Industry Globalizes: Indian Conglomerates Pioneering New Trends in Industrial Globalization
143. Lack of effect of litigation on long-term outcome after severe traumatic brain injury
144. FINANCEMENT DE L’ECONOMIE AFRICAINE : ACCOMPAGNER LA MODERNISATION DES ECONOMIES
145. From minimal signed circuits to the dynamics of Boolean regulatory networks.
146. Signes et symptômes de la sclérose en plaques
147. Diagnostics différentiels de la sclérose en plaques
148. Thérapeutiques et prise en charge de la sclérose en plaques
149. L’affiliation religieuse en droit européen des droits de l’homme
150. Diagnostic positif de la sclérose en plaques
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.